0.015
0.00 (-6.25%)
Previous Close | 0.016 |
Open | 0.016 |
Volume | 5,319,635 |
Avg. Volume (3M) | 2,346,146 |
Market Cap | 2,283,285 |
Price / Sales | 0.480 |
Price / Book | 8.95 |
52 Weeks Range | |
Earnings Date | 29 Jul 2025 - 4 Aug 2025 |
Profit Margin | -121.34% |
Operating Margin (TTM) | -120.31% |
Diluted EPS (TTM) | -0.040 |
Quarterly Revenue Growth (YOY) | 5.40% |
Total Debt/Equity (MRQ) | 434.57% |
Current Ratio (MRQ) | 0.870 |
Operating Cash Flow (TTM) | -3.09 M |
Levered Free Cash Flow (TTM) | -2.28 M |
Return on Assets (TTM) | -56.81% |
Return on Equity (TTM) | -907.51% |
Market Trend
Short Term | Medium Term | ||
Industry | Medical Instruments & Supplies (AU) | Mixed | Mixed |
Medical Instruments & Supplies (Global) | Bearish | Mixed | |
Stock | OSTEOPORE FPO [OSX] | - | - |
AIStockmoo Score
Analyst Consensus | 0.0 |
Insider Activity | NA |
Price Volatility | 0.5 |
Technical Moving Averages | 2.5 |
Technical Oscillators | -2.5 |
Average | 0.13 |
Osteopore Ltd is engaged in the production of 3D-printed bioresorbable implants that are used in conjunction with surgical procedures to assist bone healing. Its products include Osteoplug, which is a bioresorbable implant used for covering trephination burr holes in neurosurgery, and Osteomesh which is a bioresorbable implant used in craniofacial surgery. Business operating segments are based on the firm's geographical presence in Singapore and Australia. |
|
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
Investment Style | Small Value |
% Held by Insiders | 17.19% |
% Held by Institutions | 11.23% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |